Adaptive Biotechnologies (ADPT) Competitors $9.09 -0.27 (-2.88%) Closing price 04:00 PM EasternExtended Trading$9.09 0.00 (0.00%) As of 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADPT vs. TGTX, TLX, VRNA, LNTH, AXSM, GRFS, NUVL, ADMA, PCVX, and KRYSShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Verona Pharma (VRNA), Lantheus (LNTH), Axsome Therapeutics (AXSM), Grifols (GRFS), Nuvalent (NUVL), ADMA Biologics (ADMA), Vaxcyte (PCVX), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. Adaptive Biotechnologies vs. TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Verona Pharma Lantheus Axsome Therapeutics Grifols Nuvalent ADMA Biologics Vaxcyte Krystal Biotech Adaptive Biotechnologies (NASDAQ:ADPT) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking. Does the media favor ADPT or TGTX? In the previous week, TG Therapeutics had 2 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 11 mentions for TG Therapeutics and 9 mentions for Adaptive Biotechnologies. TG Therapeutics' average media sentiment score of 1.56 beat Adaptive Biotechnologies' score of 1.50 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TG Therapeutics 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts rate ADPT or TGTX? Adaptive Biotechnologies presently has a consensus price target of $9.83, suggesting a potential upside of 8.72%. TG Therapeutics has a consensus price target of $40.80, suggesting a potential upside of 19.28%. Given TG Therapeutics' higher possible upside, analysts plainly believe TG Therapeutics is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Do institutionals & insiders believe in ADPT or TGTX? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by insiders. Comparatively, 10.6% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor ADPT or TGTX? TG Therapeutics received 559 more outperform votes than Adaptive Biotechnologies when rated by MarketBeat users. Likewise, 76.27% of users gave TG Therapeutics an outperform vote while only 58.14% of users gave Adaptive Biotechnologies an outperform vote. CompanyUnderperformOutperformAdaptive BiotechnologiesOutperform Votes10058.14% Underperform Votes7241.86% TG TherapeuticsOutperform Votes65976.27% Underperform Votes20523.73% Which has stronger valuation and earnings, ADPT or TGTX? TG Therapeutics has higher revenue and earnings than Adaptive Biotechnologies. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$189.53M7.25-$159.49M-$0.96-9.42TG Therapeutics$386.39M14.05$12.67M$0.24142.53 Which has more volatility & risk, ADPT or TGTX? Adaptive Biotechnologies has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.21, indicating that its stock price is 121% more volatile than the S&P 500. Is ADPT or TGTX more profitable? TG Therapeutics has a net margin of -5.42% compared to Adaptive Biotechnologies' net margin of -89.12%. TG Therapeutics' return on equity of -8.32% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-89.12% -64.65% -26.45% TG Therapeutics -5.42%-8.32%-3.40% SummaryTG Therapeutics beats Adaptive Biotechnologies on 14 of the 18 factors compared between the two stocks. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.37B$2.92B$5.36B$8.40BDividend YieldN/A1.72%5.22%4.11%P/E Ratio-8.2930.7126.6219.74Price / Sales7.25398.27391.30117.36Price / CashN/A168.6838.2534.62Price / Book6.603.286.804.51Net Income-$159.49M-$72.17M$3.23B$248.18M7 Day Performance0.06%4.13%4.02%1.07%1 Month Performance32.43%7.50%12.19%14.96%1 Year Performance159.17%-28.22%17.04%6.70% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies3.5906 of 5 stars$9.09-2.9%$9.83+8.2%+160.7%$1.38B$189.53M-8.34790News CoveragePositive NewsGap DownTGTXTG Therapeutics3.8221 of 5 stars$34.99+4.0%$40.80+16.6%+115.2%$5.56B$386.39M-349.87290Positive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.25-5.4%$22.00+35.4%N/A$5.49B$783.21M0.00N/APositive NewsGap UpVRNAVerona Pharma2.6775 of 5 stars$67.53+6.6%$81.50+20.7%+484.7%$5.48B$118.54M-35.1730Positive NewsLNTHLantheus4.458 of 5 stars$79.52-2.7%$132.67+66.8%-7.3%$5.45B$1.54B13.23700Positive NewsHigh Trading VolumeAXSMAxsome Therapeutics4.7267 of 5 stars$110.16+2.2%$172.14+56.3%+39.7%$5.42B$432.16M-18.39380Positive NewsInsider TradeGRFSGrifols3.2195 of 5 stars$7.73+8.9%N/A+4.7%$5.31B$7.21B6.6126,300Positive NewsNUVLNuvalent2.6807 of 5 stars$73.63+5.4%$115.50+56.9%+7.0%$5.27BN/A-21.2240News CoveragePositive NewsADMAADMA Biologics3.1806 of 5 stars$20.45+2.4%$24.25+18.6%+117.2%$4.86B$459.38M73.04530News CoveragePositive NewsGap DownPCVXVaxcyte3.117 of 5 stars$31.59+1.4%$136.50+332.1%-51.8%$4.08BN/A-6.87160News CoveragePositive NewsEarnings ReportKRYSKrystal Biotech4.8578 of 5 stars$139.43+5.5%$218.63+56.8%-20.0%$4.03B$333.45M46.63210 Related Companies and Tools Related Companies TG Therapeutics Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Verona Pharma Competitors Lantheus Competitors Axsome Therapeutics Competitors Grifols Competitors Nuvalent Competitors ADMA Biologics Competitors Vaxcyte Competitors Krystal Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADPT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
